臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jen chang ko"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 106-155 / 290 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-03-11T08:34:24Z	Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells	Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Jian Y.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:23Z	Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells	Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Jian Y.-J.;Chang P.-Y.;Wang T.-J.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Jian Y.-J.; Chang P.-Y.; Wang T.-J.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:23Z	Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells	Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Jian Y.-J.;Chang P.-Y.;Wang T.-J.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Jian Y.-J.; Chang P.-Y.; Wang T.-J.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:23Z	Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells	Jen-Chang Ko;Syu J.-J.;Chen J.-C.;Wang T.-J.;Chang P.-Y.;Chen C.-Y.;Jian Y.-T.;Jian Y.-J.;Lin Y.-W.; JEN-CHANG KO; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:23Z	Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells	Jen-Chang Ko;Syu J.-J.;Chen J.-C.;Wang T.-J.;Chang P.-Y.;Chen C.-Y.;Jian Y.-T.;Jian Y.-J.;Lin Y.-W.; JEN-CHANG KO; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:23Z	Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells	Jen-Chang Ko;Wang T.-J.;Chang P.-Y.;Syu J.-J.;Chen J.-C.;Chen C.-Y.;Jian Y.-T.;Jian Y.-J.;Zheng H.-Y.;Chen W.-C.;Lin Y.-W.; JEN-CHANG KO; Wang T.-J.; Chang P.-Y.; Syu J.-J.; Chen J.-C.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Zheng H.-Y.; Chen W.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:23Z	Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells	Jen-Chang Ko;Wang T.-J.;Chang P.-Y.;Syu J.-J.;Chen J.-C.;Chen C.-Y.;Jian Y.-T.;Jian Y.-J.;Zheng H.-Y.;Chen W.-C.;Lin Y.-W.; JEN-CHANG KO; Wang T.-J.; Chang P.-Y.; Syu J.-J.; Chen J.-C.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Zheng H.-Y.; Chen W.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:22Z	Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Wang T.-J.;Zheng H.-Y.;Chen W.-C.;Chang P.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Wang T.-J.; Zheng H.-Y.; Chen W.-C.; Chang P.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:22Z	Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Wang T.-J.;Zheng H.-Y.;Chen W.-C.;Chang P.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Wang T.-J.; Zheng H.-Y.; Chen W.-C.; Chang P.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:22Z	Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities	Lee M.-R.;Tsai C.-J.;Hu J.-Y.;Lee S.-W.;Jen-Chang Ko;Wang H.-C.;Yu C.-J.;Lee L.-N.;Hsueh P.-R.; MENG-RUI LEE; Chia-Jung Tsai; Jia-Ying Hu; Shih-Wei Lee; JEN-CHANG KO; Hao-Chien Wang; Chong-Jen Yu; Li-Na Lee; Po-Ren Hsueh
臺大學術典藏	2021-03-11T08:34:22Z	Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities	Lee M.-R.;Tsai C.-J.;Hu J.-Y.;Lee S.-W.;Jen-Chang Ko;Wang H.-C.;Yu C.-J.;Lee L.-N.;Hsueh P.-R.; MENG-RUI LEE; Chia-Jung Tsai; Jia-Ying Hu; Shih-Wei Lee; JEN-CHANG KO; Hao-Chien Wang; Chong-Jen Yu; Li-Na Lee; Po-Ren Hsueh
臺大學術典藏	2021-03-11T08:34:22Z	Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells	Pan C.-H.;Chang Y.-F.;Lee M.-S.;Wen B.-C.;Jen-Chang Ko;Liang S.-K.;Liang M.-C.; Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; SHENG-KAI LIANG; Liang M.-C.
臺大學術典藏	2021-03-11T08:34:22Z	Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells	Pan C.-H.;Chang Y.-F.;Lee M.-S.;Wen B.-C.;Jen-Chang Ko;Liang S.-K.;Liang M.-C.; Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; SHENG-KAI LIANG; Liang M.-C.
臺大學術典藏	2021-03-11T08:34:21Z	Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis	Lee M.-R.;Huang Y.-P.;Kuo Y.-T.;Luo C.-H.;Shih Y.-J.;Shu C.-C.;Wang J.-Y.;Jen-Chang Ko;Yu C.-J.;Lin H.-H.; MENG-RUI LEE; Ya-Ping Huang; Yu-Ting Kuo; Chen-Hao Luo; Yun-Ju Shih; Chin-Chung Shu; Jann-Yuan Wang; JEN-CHANG KO; Chong-Jen Yu; Hsien-Ho Lin
臺大學術典藏	2021-03-11T08:34:21Z	Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis	Lee M.-R.;Huang Y.-P.;Kuo Y.-T.;Luo C.-H.;Shih Y.-J.;Shu C.-C.;Wang J.-Y.;Jen-Chang Ko;Yu C.-J.;Lin H.-H.; MENG-RUI LEE; Ya-Ping Huang; Yu-Ting Kuo; Chen-Hao Luo; Yun-Ju Shih; Chin-Chung Shu; Jann-Yuan Wang; JEN-CHANG KO; Chong-Jen Yu; Hsien-Ho Lin
臺大學術典藏	2021-03-11T08:34:21Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:21Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:21Z	Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression	Jen-Chang Ko;Zheng H.-Y.;Chen W.-C.;Peng Y.-S.;Wu C.-H.;Wei C.-L.;Chen J.-C.;Lin Y.-W.; JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:21Z	Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression	Jen-Chang Ko;Zheng H.-Y.;Chen W.-C.;Peng Y.-S.;Wu C.-H.;Wei C.-L.;Chen J.-C.;Lin Y.-W.; JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:20Z	Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan	Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏	2021-03-11T08:34:20Z	Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan	Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏	2021-03-11T08:34:20Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:20Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:20Z	Cementing an unwanted relationship	Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏	2021-03-11T08:34:20Z	Cementing an unwanted relationship	Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:17Z	Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study	Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏	2021-03-11T08:34:17Z	Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study	Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:34:17Z	Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:17Z	Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-03-11T08:34:16Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-03-11T08:34:16Z	Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review	Lee M.-R.;Chang L.-Y.;Jen-Chang Ko;Wang H.-C.;Huang Y.-W.; MENG-RUI LEE; LIH-YU CHANG; JEN-CHANG KO; Wang H.-C.; Huang Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review	Lee M.-R.;Chang L.-Y.;Jen-Chang Ko;Wang H.-C.;Huang Y.-W.; MENG-RUI LEE; LIH-YU CHANG; JEN-CHANG KO; Wang H.-C.; Huang Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells	Jen-Chang Ko;Chen J.-C.;Yen T.-C.;Chen T.-Y.;Ma P.-F.;Lin Y.-C.;Cheng H.-H.;Taso Y.-C.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells	Jen-Chang Ko;Chen J.-C.;Yen T.-C.;Chen T.-Y.;Ma P.-F.;Lin Y.-C.;Cheng H.-H.;Taso Y.-C.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:15Z	Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination	Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T.

顯示項目 106-155 / 290 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51926903 線上人數 : 1062 教育部委託研究計畫計畫執行:國立臺灣大學圖書館